Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 161,827Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 39ARCUTIS

02 6ASTRAZENECA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11129818

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3712

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-25

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 9907788

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3712

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 9907788

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3408

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11129818

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3408

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-25

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 12005051

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3970

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11992480

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3970

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11819496

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3970

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11129818

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3970

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-25

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11992480

Drug Substance Claim :

Drug Product Claim :

Application Number : 217242

Patent Use Code : U-3773

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ROFLUMILAST

US Patent Number : 11992480

Drug Substance Claim :

Drug Product Claim :

Application Number : 215985

Patent Use Code : U-3748

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-07

blank